School of Medicine

Showing 1-5 of 5 Results

• 

  Lawrence Leung

  Maureen Lyles D'Ambrogio Professor in the School of Medicine

  Current Research and Scholarly Interests Our long term interest is to have a better understanding of the natural antithrombotic pathways and the pathophysiology of vascular thrombosis. We have focused on thrombin, the key enzyme in the blood clotting cascade.Our goal is to develop new antithrombotic agents and devise new diagnostic tests for vascular thrombotic disorders.

• Lee Levitt

  Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus

  Current Research and Scholarly Interests Low molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.

• 

  Michaela Liedtke

  Associate Professor of Medicine (Hematology) at the Stanford University Medical Center

  Current Research and Scholarly Interests 1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis
  
  2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)
  
  3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis
  
  4) Characterization of the molecular mechanism of MLL-induced acute leukemia

• 

  Zhongqi (Jason) Lin

  Life Science Research Professional, Medicine - Med/Hematology

• 

  Yuan-Hung Lo

  Postdoctoral Research Fellow, Hematology

  Bio I am currently working on several projects to understand the control of gastrointestinal and cancer stem cell biology, especially how critical intrinsic genetic mutations and extrinsic extracellular components within the microenvironment influence cell behaviors. Stem cells of the gastrointestinal tract give rise to the surface lining of the epithelium, and must continuously produce new cells to replace those shed into the lumen throughout the lifespan. When mutations accumulate in these stem cells, they can grow uncontrollably into benign polyps or malignant tumors. In Dr. Calvin Kuo?s laboratory, I have used transgenic mice and primary human organoids as the models. Human organoids provide a robust primary culture system to recapitulate 3D structure and multilineage differentiation, which represents an underutilized method for the study of stem cell and cancer biology. I have focused my efforts on establishing next generation CRISPR/Cas9 genome editing tools in these orgnaoids, and applying this powerful system to gain insight into how different signaling pathways can contribute to gastrointestinal stem cell activity and tumorigenesis .